Partnerships: boosting value & accelerating progress
At Domain, we transform science into life-changing therapies by harnessing the power of the immune system to improve patients’ lives.
Strategic partnerships lie at the heart of our mission, enabling us to push scientific boundaries and address significant unmet medical needs. We work closely with leading pharmaceutical and biotech companies, as well as academic pioneers, leveraging collective expertise to create synergy, tackle long-standing research challenges, and accelerate the development of our GPCR-targeting drug discovery assets.
As a trusted partner, we are deeply committed to success at every stage, from discovery to clinical development. By combining our deep expertise in the GPCR field, cutting-edge science, and drawing on collective knowledge, we create sustainable value that benefits not only our partners but, most importantly, delivers transformative outcomes for patients worldwide.
Partnerships
Precision Medicine and Immunotherapy of Sarcoma

M1069
A2aR/A2bR antagonist
Solid Tumors

MC4 small molecule pharmacochaperone
Rare metabolic diseases

Multi-target collaboration for rare diseases